Focal adhesion kinase 1 (PTK2) mRNA (PTK2 mRNA)

PTK2 mRNA is the messenger RNA transcript that encodes Focal Adhesion Kinase (FAK), a critical non-receptor tyrosine kinase involved in cellular adhesion, motility, and survival signaling (UniProt: Q05397; NCBI Gene: 5747). FAK serves as a key mediator between the extracellular matrix and the actin cytoskeleton, integrating signals from integrins and growth factor receptors to regulate various downstream pathways like PI3K/Akt and MAPK/ERK. In many human malignancies, PTK2 mRNA is significantly overexpressed, leading to high levels of FAK protein which promote tumor cell invasion, epithelial-mesenchymal transition (EMT), and resistance to apoptosis (PubMed: PMID 15150101). Targeting the PTK2 mRNA directly using RNA interference (RNAi) or antisense oligonucleotides (ASOs) represents a therapeutic strategy to deplete the FAK protein pool entirely, addressing both its kinase-dependent and kinase-independent scaffolding functions. While small molecule inhibitors of FAK are more common in clinical trials, mRNA-targeted approaches are being explored in preclinical models to achieve more potent and specific inhibition of FAK-driven oncogenic processes (PubMed: PMID 24651434). This approach is particularly relevant in metastatic cancers and fibrotic diseases where FAK signaling is aberrantly activated.

Other names

FAK mRNAProtein tyrosine kinase 2 mRNAFADK 1 mRNApp125FAK mRNAFocal adhesion kinase-related non-kinase mRNA

RNA interference (RNAi) or antisense-mediated degradation of the PTK2 transcript to inhibit protein synthesis.